NASDAQ:ENDP Endo International (ENDP) Stock Price, News & Analysis → A Silent Invasion of America (From The Freeport Society) (Ad) Free ENDP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.28▼$0.7552-Week Range N/AVolume9,967 shsAverage Volume28.19 million shsMarket Capitalization$141,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesSustainabilityTrendsStock AnalysisHeadlinesSustainabilityTrends Get Endo International alerts: Email Address Ad Porter & CompanyThe Key to this $10 Trillion Tech BoomPresident Biden has just approved $2.6 billion for this breakthrough technology… And it has nothing to do with artificial intelligence, cryptocurrency, or the blockchain.To get all the details of this new tech – click here now. About Endo International Stock (NASDAQ:ENDP)Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.Read More Ad Porter & CompanyThe Key to this $10 Trillion Tech BoomPresident Biden has just approved $2.6 billion for this breakthrough technology… And it has nothing to do with artificial intelligence, cryptocurrency, or the blockchain.To get all the details of this new tech – click here now. ENDP Stock News HeadlinesJune 13 at 3:06 AM | benzinga.comHillary Clinton Endorses George Latimer Over NY Rep. Jamaal Bowman: 'With Trump On The Ballot, We Need Strong, Principled Democrats In Congress'June 4, 2024 | investorplace.comIvy League Inspiration: 3 Stocks That Harvard’s Endowment Managers Believe InMay 19, 2024 | benzinga.com'Sickening' — Trump's NRA Endorsement Slammed By Birmingham MayorMay 15, 2024 | yahoo.comEndo Pharmaceuticals Looks For AcquisitionsMay 14, 2024 | msn.com'Endo has stolen so much': Traveling with endometriosis requires planningMay 9, 2024 | msn.comMalvern-Based Endo Hit with Court-Ordered Penalty for False MarketingMay 3, 2024 | marketwatch.comEndo Health Solutions Will Pay Over $1.5 Billion in Opioid Criminal CaseApril 30, 2024 | insidebitcoins.comCronos Price Prediction: CRO Surges 4% After Eminem Endorses Crypto.com As Experts Say Buy The Dip With This New Green CryptoApril 28, 2024 | msn.comEndo, Inc. Completes Asset Acquisition from Endo International, Eyes Growth Post-RestructuringApril 22, 2024 | markets.businessinsider.comEndo International's Par Pharmaceutical Expands Recall Of Treprostinil InjectionApril 13, 2024 | financialpost.comC.K. McWhorter Endows Maison Goyard With Esteemed McWhorter Family Trust Warrant Of ExcellenceApril 13, 2024 | financialpost.comC.K. McWhorter Endows Wimbledon Championships With Esteemed McWhorter Family Trust Warrant Of ExcellenceApril 13, 2024 | bloomberg.comEndo Sells $2.5 Billion of Debt to Fund Its Exit From BankruptcyApril 10, 2024 | benzinga.comAmphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused CompaniesApril 2, 2024 | financialpost.comC.K. McWhorter Endows Gulfstream Aerospace with Prestigious McWhorter Family Trust Warrant for Excellence in Sustainable Luxury AviationMarch 30, 2024 | financialpost.comC.K. McWhorter Endows Tems’ ‘Me & U’ Music Video with Esteemed McWhorter Family Trust Global Digital Archive Family Trust Warrant Of ExcellenceMarch 29, 2024 | msn.comSelf-compassion could help endometriosis sufferersMarch 26, 2024 | bitcoinist.comScoring A Win: Mastercard Endorses Ripple For Global Remittances – A Boost For XRP?March 19, 2024 | wsj.comGeorge Lucas Endorses Disney and CEO Bob Iger in Proxy FightMarch 19, 2024 | reuters.comDrugmaker Endo receives US court approval for bankruptcy restructuringMarch 16, 2024 | finance.yahoo.comEndo International plc (ENDP)March 15, 2024 | bitcoinist.comXRP Scores Regulatory Win: European Governance Institute Endorses Non-Security StatusMarch 13, 2024 | financialpost.comAmerican Perceptions Shift from Skepticism to Endorsement with Direct AI Engagement, according to Insurity’s 2024 AI in Insurance ReportMarch 12, 2024 | bitcoinist.comRap Star Drake Brings Bitcoin To The Masses With Saylor VideoMarch 9, 2024 | benzinga.comFormer House Speaker Nancy Pelosi Labels Mitch McConnell's Trump Endorsement As 'Sad, Professional Tragedy'See More Headlines Receive ENDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Endo International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today6/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ENDP CUSIP29264F20 CIK1593034 Webwww.endo.com Phone(531) 268-2000Fax800-329-3636Employees3,103Year Founded1997Profitability EPS (Most Recent Fiscal Year)($11.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-613,240,000.00 Net Margins-93.31% Pretax Margin-91.14% Return on Equity-34.25% Return on Assets6.72% Debt Debt-to-Equity RatioN/A Current Ratio1.86 Quick Ratio1.62 Sales & Book Value Annual Sales$2.99 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.06 Book Value($13.60) per share Price / BookN/AMiscellaneous Outstanding Shares235,143,000Free Float232,321,000Market Cap$141,000.00 OptionableNo Data Beta1.15 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Blaise A. Coleman (Age 48)Pres, CEO & Director Comp: $20.93MMr. Mark T. Bradley (Age 52)Exec. VP & CFO Comp: $6.27MMr. Matthew Joseph Maletta (Age 50)Exec. VP, Chief Legal Officer & Company Sec. Comp: $7.02MMr. Patrick A. Barry (Age 54)Exec. VP & Pres of Global Commercial Operations Comp: $6.15MFrank B. RacitiVP, Controller & Chief Accounting OfficerMs. Cheryl StouchSr. VP of Information Technology & Chief Information OfficerMs. Laure E. ParkSr. VP of Investor Relations & Corp. AffairsMs. Susan WilliamsonSr. VP & Chief Compliance OfficerMs. Tracy BassoChief HR OfficerMr. James PappHead of Endo Ventures Limited & Sr. VP of Global Supply ChainMore ExecutivesKey CompetitorsAthenexNASDAQ:ATNXPMV PharmaceuticalsNASDAQ:PMVPRepare TherapeuticsNASDAQ:RPTXEpizymeNASDAQ:EPZMMacroGenicsNASDAQ:MGNXView All Competitors ENDP Stock Analysis - Frequently Asked Questions How were Endo International's earnings last quarter? Endo International plc (NASDAQ:ENDP) issued its earnings results on Thursday, November, 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.34. The business earned $772.03 million during the quarter, compared to the consensus estimate of $667.94 million. Endo International had a negative trailing twelve-month return on equity of 34.25% and a negative net margin of 93.31%. The company's revenue for the quarter was up 21.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.52 EPS. What is Paul Campanelli's approval rating as Endo International's CEO? 25 employees have rated Endo International Chief Executive Officer Paul Campanelli on Glassdoor.com. Paul Campanelli has an approval rating of 86% among the company's employees. What other stocks do shareholders of Endo International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Endo International investors own include Teva Pharmaceutical Industries (TEVA), Bausch Health Companies (BHC), Mallinckrodt (MNK), Gilead Sciences (GILD), TherapeuticsMD (TXMD), Micron Technology (MU), Cleveland-Cliffs (CLF), Pfizer (PFE), Advanced Micro Devices (AMD) and NVIDIA (NVDA). This page (NASDAQ:ENDP) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endo International plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Endo International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.